Elevated levels of soluble ICAM-1 in serum and BAL fluid in patients with active sarcoidosis.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Chest

• Publication date

  1995-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1378/CHEST.107.6.1636PMID 7781359
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interlobar variation in the recovery of bronchoalveolar lavage fluid, cell populations, and angiotensin-converting enzyme in normal volunteers.

  1993cited by this paper
• Elevated levels of soluble ICAM‐1 in sera from patients with bronchial asthma

  1993cited by this paper
• Identical expression of ELAM‐1, VCAM‐1, and ICAM‐1 in sarcoidosis and usual interstitial pneumonitis

  1993cited by this paper
• Increased levels of circulating intercellular adhesion molecule 1 in Kawasaki disease.

  1992cited by this paper
• Expression of alveolar macrophage adhesion molecules in pulmonary sarcoidosis.

  1992cited by this paper
• Circulating intercellular adhesion molecule 1 as a marker of disease progression in cutaneous melanoma.

  1992cited by this paper
• Detection of circulating intercellular adhesion molecule–1 in chronic liver diseases

  1992cited by this paper
• Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells.

  1992cited by this paper
• Detection of circulating intercellular adhesion molecule‐1 antigen in malignant diseases

  1991cited by this paper
• A form of circulating ICAM-1 in human serum.

  1991cited by this paper
• Increased expression of leukocyte function associated antigen-1 (LFA-1) and intercellular adhesion molecule-1 (ICAM-1) by alveolar macrophages of patients with pulmonary sarcoidosis.

  1991cited by this paper
• Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes.

  1991cited by this paper
• Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders.

  1991cited by this paper
• Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity.

  1991cited by this paper
• Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma.

  1991cited by this paper
• Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma.

  1990cited by this paper
• Importance of ICAM-1 for accessory cell function of monocytic cells.

  1990cited by this paper
• The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells.

  1990cited by this paper
• In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts.

  1990cited by this paper
• Association of intercellular adhesion molecule 1 with the multichain high-affinity interleukin 2 receptor.

  1990cited by this paper
• The effect of anti-intercellular adhesion molecule-1 on phorbol-ester-induced rabbit lung inflammation.

  1989cited by this paper
• Elevated concentrations of soluble interleukin-2 receptors in serum samples and bronchoalveolar lavage fluids in active sarcoidosis.

  1988cited by this paper
• Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-inflammatory cytokines. Regulation by pharmacologic agents and neutralizing antibodies.

  1988cited by this paper
• Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1).

  1987cited by this paper
• Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1).

  1986cited by this paper
• Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis.

  1984cited by this paper
• Comparison of gallium-67 scanning, bronchoalveolar lavage, and serum angiotensin-converting enzyme levels in pulmonary sarcoidosis. Predicting response to therapy.

  1984cited by this paper
• Human malignant melanoma

  1979cited by this paper

• Inflammatory profiles in plasma and cerebrospinal fluid of patients with neurosarcoidosis.

  2022cites this paper
• Angiogenesis modulation by exogenous antioxidants

  2017cites this paper
• Screening for Differentially Expressed Proteins Relevant to the Differential Diagnosis of Sarcoidosis and Tuberculosis

  2015cites this paper
• Is Analysis of Exhaled Breath Condensate an Equivalent to Bronchoalveolar Lavage Fluid in Sarcoidos is Patients

  2012cites this paper
• N-acetylcysteine inhibits IL-8 and MMP-9 release and ICAM-1 expression by bronchoalveolar cells from interstitial lung disease patients

  2010cites this paper
• Shed soluble ICAM-1 molecules in bronchoalveolar lavage cell supernatants and serum of patients with pulmonary sarcoidosis

  2009cites this paper
• Sarcoidosis

  2009cites this paper
• Untersuchung der Spezifität antiviraler Faktoren in der broncho-alveolären Lavage

  2009influential citation
• Upregulation of I-CAM1 in response to beryllium exposure in small airway epithelial cells.

  2008cites this paper
• Perforin down-regulation and adhesion molecules activation in pulmonary sarcoidosis: an induced sputum and BAL study.

  2006cites this paper
• Elevated levels of circulating adhesion molecules in patients with active pulmonary tuberculosis

  2003cites this paper
• Biologically active intercellular adhesion molecule-1 is shed as dimers by a regulated mechanism in the inflamed pleural space.

  2003cites this paper
• Elevation of Serum KL-6 Levels in Patients with Hematological Malignancies Associated with Cytomegalovirus or Pneumocystis carinii Pneumonia

  2002cites this paper
• Applied clinical immunology in sarcoidosis

  2002cites this paper
• The gene polymorphism of tumor necrosis factor-beta, but not that of tumor necrosis factor-alpha, is associated with the prognosis of sarcoidosis.

  2001cites this paper
• [Biological manifestations of sarcoidosis].

  2001cites this paper
• Intercellular adhesion molecule-1 in patients with idiopathic interstitial pneumonia.

  2001cites this paper
• Serum amyloid A and high‐density lipoprotein cholesterol: serum markers of inflammation in sarcoidosis and other systemic disorders

  2001cites this paper
• The Gene Polymorphism of Tumor Necrosis Factor-β, But Not That of Tumor Necrosis Factor-α, Is Associated With the Prognosis of Sarcoidosis

  2001cites this paper
• Elevated levels of soluble adhesion molecules in sera and BAL fluid of individuals infected with human T-cell lymphotropic virus type 1.

  2000cites this paper
• Inflammation markers in the serum of salt miners.

  2000cites this paper
• LUNG INJURY, INFLAMMATION, AND INFLAMMATORY STIMULI IN RATS EXPOSED TO OZONE

  2000cites this paper
• Possible role of l‐selectin in T lymphocyte alveolitis in patients with active pulmonary sarcoidosis

  2000cites this paper
• Inflammation markers in the serum of salt miners

  2000cites this paper
• Inflammation markers in the serum of salt miners

  2000cites this paper
• The value of interleukin-12 as an activity marker of pulmonary sarcoidosis.

  1999cites this paper
• Soluble intercellular adhesion molecule-1 as an early detection marker for radiation pneumonitis.

  1999cites this paper
• Value of ICAM-1 expression and soluble ICAM-1 level as a marker of activity in sarcoidosis.

  1999cites this paper
• Sarcoidosis: clinical manifestations, staging and therapy (Part II).

  1998cites this paper
• Serum markers for the staging of disease activity of sarcoidosis and other interstitial lung diseases of unknown etiology.

  1998cites this paper
• Marcadores de actividade das doenças do interstício pulmonar: situação actual**Trabalho apresentado no XIII Congresso de Pneumologia da SPP, em Nov 97 em Lisboa, na sessão "Revisōes de literatura – Patologia do intersticio".

  1998cites this paper
• The lymphocytic alveolitis in sarcoidosis is associated with increased amounts of soluble and cell‐bound adhesion molecules in bronchoalveolar lavage fluid and serum

  1998cites this paper
• The enhanced inflammatory response in non-small cell lung carcinoma is not reflected in the alveolar compartment.

  1998cites this paper
• [Serum soluble adhesion molecules in patients with sarcoidosis].

  1997cites this paper
• Inhibition of airway inflammation in rDer f 2-sensitized mice by oral administration of recombinant der f 2.

  1997cites this paper
• Immunological, clinical and molecular aspects of sarcoidosis.

  1997cites this paper
• Differential display of messenger RNA expressed in bronchoalveolar lavage cells in pulmonary sarcoidosis patients.

  1996cites this paper
• [Use of the the ED046 kit to analyze serum KL-6 in patients with pneumonitis].

  1996cites this paper
• Circulating soluble intercellular adhesion molecule‐1 (sICAM‐1) in patients with sarcoidosis

  1996cites this paper